| Ident. | Authors (with country if any) | Title |
|---|
| 000008 (2020) |
Yaseen M. Arabi [Arabie saoudite] ; Ayed Y. Asiri [Arabie saoudite] ; Abdullah M. Assiri [Arabie saoudite] ; Hani A. Aziz Jokhdar [Arabie saoudite] ; Adel Alothman [Arabie saoudite] ; Hanan H. Balkhy [Arabie saoudite] ; Sameera Aljohani [Arabie saoudite] ; Shmeylan Al Harbi [Arabie saoudite] ; Suleiman Kojan [Arabie saoudite] ; Majed Al Jeraisy [Arabie saoudite] ; Ahmad M. Deeb [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] ; Sameeh Ghazal [Arabie saoudite] ; Sarah Al Faraj [Arabie saoudite] ; Fahad Al-Hameed [Arabie saoudite] ; Asim Alsaedi [Arabie saoudite] ; Yasser Mandourah [Arabie saoudite] ; Ghaleb A. Al Mekhlafi [Arabie saoudite] ; Nisreen Murad Sherbeeni [Arabie saoudite] ; Fatehi Elnour Elzein [Arabie saoudite] ; Abdullah Almotairi [Arabie saoudite] ; Ali Al Bshabshe [Arabie saoudite] ; Ayman Kharaba [Arabie saoudite] ; Jesna Jose [Arabie saoudite] ; Abdulrahman Al Harthy [Arabie saoudite] ; Mohammed Al Sulaiman [Arabie saoudite] ; Ahmed Mady [Arabie saoudite, Égypte] ; Robert A. Fowler [Canada] ; Frederick G. Hayden ; Abdulaziz Al-Dawood [Arabie saoudite] ; Mohamed Abdelzaher [Arabie saoudite, Égypte] ; Wail Bajhmom [Arabie saoudite] ; Mohamed A. Hussein [Arabie saoudite] | Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial |
| 000025 (2020) |
Muhammad Tahir Ul Qamar [République populaire de Chine] ; Safar M. Alqahtani [Arabie saoudite] ; Mubarak A. Alamri [Arabie saoudite] ; Ling-Ling Chen [République populaire de Chine] | Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants† |
| 000028 (2020) |
Afnan A. Degnah [Arabie saoudite] ; Sawsan S. Al-Amri [Arabie saoudite] ; Ahmed M. Hassan [Arabie saoudite] ; Abdulrahman S. Almasoud [Arabie saoudite] ; Manar Mousa [Arabie saoudite] ; Sarah A. Almahboub [Arabie saoudite] ; Rowa Y. Alhabbab [Arabie saoudite] ; Ahmed A. Mirza [Arabie saoudite] ; Salwa I. Hindawi [Arabie saoudite] ; Naif Khalaf Alharbi [Arabie saoudite] ; Esam I. Azhar [Arabie saoudite] ; Anwar M. Hashem [Arabie saoudite] | Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 |
| 000057 (2020) |
Ziad A. Memish [Arabie saoudite, États-Unis] ; Stanley Perlman [États-Unis] ; Maria D. Van Kerkhove [Suisse] ; Alimuddin Zumla [Royaume-Uni] | Middle East respiratory syndrome |
| 000060 (2020) |
Abdulkarim Al-Rabiaah [Arabie saoudite] ; Mohamad-Hani Temsah [Arabie saoudite] ; Ayman A. Al-Eyadhy [Arabie saoudite] ; Gamal M. Hasan [Arabie saoudite, Égypte] ; Fahad Al-Zamil [Arabie saoudite] ; Sarah Al-Subaie [Arabie saoudite] ; Fahad Alsohime [Arabie saoudite] ; Amr Jamal [Arabie saoudite] ; Ali Alhaboob [Arabie saoudite] ; Basma Al-Saadi [Arabie saoudite] ; Ali Mohammed Somily [Arabie saoudite] | Middle East Respiratory Syndrome-Corona Virus (MERS-CoV) associated stress among medical students at a university teaching hospital in Saudi Arabia |
| 000093 (2020) |
Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Ziad A. Memish [Arabie saoudite] | Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV |
| 000096 (2020) |
Asmaa Altamimi [Arabie saoudite] ; Raghib Abu-Saris [Arabie saoudite] ; Ashraf El-Metwally [Arabie saoudite] ; Taghreed Alaifan [Arabie saoudite] ; Aref Alamri [Arabie saoudite] | Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory |
| 000098 (2020) |
A. Tolah [Arabie saoudite] ; S. Al Masaudi [Arabie saoudite] ; S. El-Kafrawy [Arabie saoudite] ; A. Mirza [Arabie saoudite] ; S. Harakeh [Arabie saoudite] ; A. Hassan [Arabie saoudite] ; A. Alzahrani [Arabie saoudite] ; G. Alsaaidi [Arabie saoudite] ; A. Alagaili [Arabie saoudite] ; A. Hashem [Arabie saoudite] ; E. Azhar [Arabie saoudite] | Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia, 2016-2018 |
| 000099 (2020) |
Yaseen M. Arabi [Arabie saoudite] ; Robert Fowler [Canada] ; Frederick G. Hayden [États-Unis] | Critical care management of adults with community-acquired severe respiratory viral infection |
| 000119 (2020) |
Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] | Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19) |
| 000122 (2020) |
Abdullah Sheikh [Arabie saoudite] ; Abdulla Al-Taher [Arabie saoudite] ; Mohammed Al-Nazawi [Arabie saoudite] ; Abdullah I. Al-Mubarak [Arabie saoudite] ; Mahmoud Kandeel [Arabie saoudite, Égypte] | Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design |
| 000157 (2019) |
Esam I. Azhar [Arabie saoudite] ; David S. C. Hui [Hong Kong] ; Ziad A. Memish [Arabie saoudite] ; Christian Drosten [Allemagne] ; Alimuddin Zumla [Royaume-Uni] | The Middle East Respiratory Syndrome (MERS) |
| 000179 (2019) |
Khalid Al-Ahmadi [Arabie saoudite] ; Sabah Alahmadi [Arabie saoudite] ; Ali Al-Zahrani [Arabie saoudite] | Spatiotemporal Clustering of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Incidence in Saudi Arabia, 2012–2019 |
| 000180 (2019) |
Maged Gomaa Hemida [Arabie saoudite, Égypte] ; Abdelmohsen Alnaeem [Arabie saoudite] | Some One Health based control strategies for the Middle East respiratory syndrome coronavirus |
| 000196 (2019) |
Yaseen M. Arabi [Arabie saoudite] ; Sarah Shalhoub [Canada] ; Yasser Mandourah ; Fahad Al-Hameed ; Awad Al-Omari ; Eman Al Qasim [Arabie saoudite] ; Jesna Jose [Arabie saoudite] ; Basem Alraddadi ; Abdullah Almotairi ; Kasim Al Khatib ; Ahmed Abdulmomen ; Ismael Qushmaq ; Anees A. Sindi ; Ahmed Mady [Arabie saoudite, Égypte] ; Othman Solaiman ; Rajaa Al-Raddadi ; Khalid Maghrabi ; Ahmed Ragab ; Ghaleb A. Al Mekhlafi ; Hanan H. Balkhy ; Abdulrahman Al Harthy [Arabie saoudite] ; Ayman Kharaba ; Jawaher A. Gramish ; Abdulsalam M. Al-Aithan [Arabie saoudite] ; Abdulaziz Al-Dawood [Arabie saoudite] ; Laura Merson [Royaume-Uni] ; Frederick G. Hayden [Royaume-Uni] ; Robert Fowler [Canada] | Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study |
| 000204 (2019) |
Sarah Batawi [Arabie saoudite] ; Nehal Tarazan [Arabie saoudite] ; Rajaa Al-Raddadi [Arabie saoudite] ; Eman Al Qasim [Arabie saoudite] ; Anees Sindi [Arabie saoudite] ; Sameera Al Johni [Arabie saoudite] ; Fahad M. Al-Hameed [Arabie saoudite] ; Yaseen M. Arabi [Arabie saoudite] ; Timothy M. Uyeki ; Basem M. Alraddadi [Arabie saoudite] | Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS) |
| 000215 (2019) |
Bandar Abdulmohsen Al Knawy [Arabie saoudite] ; Hanan M F. Al-Kadri [Arabie saoudite] ; Mahmoud Elbarbary [Arabie saoudite] ; Yaseen Arabi [Arabie saoudite] ; Hanan H. Balkhy [Arabie saoudite] ; Alex Clark [Canada] | Perceptions of postoutbreak management by management and healthcare workers of a Middle East respiratory syndrome outbreak in a tertiary care hospital: a qualitative study |
| 000216 (2019) |
Sabeena Mustafa [Arabie saoudite] ; Hanan Balkhy [Arabie saoudite] ; Musa Gabere [Arabie saoudite] | Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach |
| 000224 (2019) |
Abbas Al Mutair [Arabie saoudite, Australie] ; Zainab Ambani [Arabie saoudite] | Narrative review of Middle East respiratory syndrome coronavirus
(MERS-CoV) infection: updates and implications for practice |
**** probable Xml problem ****
| 000231 |
|
